Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars, Humira, AbbVie, rebates, drug pricing, Amgen, Celltrion, Novartis, Boehringer Ingelheim, Biocon, Fresenius, Sandoz, Organon, Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie, Skyrizi, Amgen, Otezla, Boehringer Ingelheim, psoriasis
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Mon, 07/24/23 - 10:24 am
Tags:
Horizon Therapeutics, Amgen, lupus, daxdilimab, clinical trials
FTC, Amgen Break Off Settlement Talks Over Horizon Deal
BioSpace
Thu, 07/20/23 - 10:07 am
Tags:
Amgen, Horizon Therapeutics, M&A, FTC
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
Tags:
M&A, Amgen, Astellas, Eli Lilly, GSK, Horizon Therapeutics, Merck, Novartis, Pfizer, Seagen
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
BioSpace
Fri, 06/23/23 - 09:53 am
Tags:
Amgen, Horizon Therapeutics, M&A, FTC
Amgen granted full FDA approval for blood cancer treatment
Biopharma Reporter
Thu, 06/22/23 - 10:10 am
Tags:
Amgen, Blincyto, FDA, blood cancer
Full circle for Paul Burton as Moderna exec returns to Amgen, this time for expanded CMO role
Fierce Biotech
Wed, 06/14/23 - 06:33 pm
Tags:
Amgen, Moderna Therapeutics, Paul Burton, chief medical officers
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Tags:
Medicare, Inflation Reduction Act, drug pricing, Amgen, Sanofi, Seagen
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
Tags:
biosimilars, biologics, drug pricing, Roche, Herceptin, Amgen, Kanjinti, Viatris, Ogivri, Pfizer, Trazimera, Teva Pharmaceutical, Herzuma, Organon, Ontruzant
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Wed, 06/7/23 - 11:15 am
Tags:
Amgen, Horizon Therapeutics, FTC, M&A
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Mon, 06/5/23 - 10:21 am
Tags:
Amgen, Horizon Therapeutics, FTC, M&A
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
Tags:
obesity, weight loss, Novo Nordisk, Eli Lilly, Pfizer, Amgen
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
Tags:
FTC, M&A, Amgen, Horizon Therapeutics, Pfizer, Seagen
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Tags:
Astellas, Iveric Bio, Bayer, Amgen, M&A
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
Tags:
JNJ, Amgen, patents, Stelara, biosimilars, legal
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Thu, 05/18/23 - 08:42 pm
Tags:
Horizon Therapeutics, M&A, Amgen, FTC
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Tags:
Supreme Court, Amgen, Sanofi, Regeneron, patents, Repatha, legal
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
Tags:
gout, Selecta Biosciences, Sobi, SEL-212, 3SBio, Amgen, Arthrosi Therapeutics, Atom Bioscience, Dyve Biosciences, Hinova Pharmaceuticals, Horizon Therapeutics, InventisBio, Jiangsu Hengrui Pharmaceuticals, JW Group, LG Chem, Olatec Therapeutics, Shanton Bioscience
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Tags:
Amgen, Horizon Therapeutics, FTC, Regeneron, antitrust, M&A, Leonard Schleifer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.